Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 8694833 | HLA-DR (HLA-DR) | retinoic | NA | vitamin | NA | positive+negation | |
| NA | |||||||
| 9279368 | HLA-DR (HLA-DR) | acute promyelocytic leukemia | NA | NA | NA | only_studied | |
| this report describes a unique case of acute promyelocytic leukemia (apl) showing elusive morphologic features, an atypical pattern of cytochemical reactions, and a previously unreported immunophenotype consistent with a very early myeloid form: cd13 (+), cd33 (+), cd9 (+), cd2 (+), hla-dr (-), cd34 (+), cd117 (+), and tdt (+). | |||||||
| 9816208 | HLA-DRB1*11 | acute promyelocytic leukemia | NA | NA | NA | unclassified | |
| in previous studies, it was shown that the fusion region of the pml/rar-alpha protein, expressed by acute promyelocytic leukemia (apl) cells, can be specifically recognized in vitro by donor (d. e. ) cd4 t cells in a hla class ii dr11-restricted fashion. | |||||||
| 14513040 | HLA IDENTICAL (HLA-IDENTICAL) | acute promyelocytic leukemia | NA | NA | NA | unclassified | |
| in all, 17 consecutive patients in hematological complete remission (hcr) of acute promyelocytic leukemia (apl) received allogeneic stem cell transplantation (sct) from an hla-identical sibling and were monitored by reverse transcriptase polymerase chain reaction of pml/raralpha prior and after transplant. | |||||||
| 14513040 | HLA IDENTICAL (HLA-IDENTICAL) | stem cell transplantation | NA | NA | NA | unclassified | |
| in all, 17 consecutive patients in hematological complete remission (hcr) of acute promyelocytic leukemia (apl) received allogeneic stem cell transplantation (sct) from an hla-identical sibling and were monitored by reverse transcriptase polymerase chain reaction of pml/raralpha prior and after transplant. | |||||||
| 19374802 | HLA-DR (HLA-DR) | acute promyelocytic leukemia | French American | NA | NA | unclassified | |
| the patients with acute promyelocytic leukemia were characterized by the absence of hla-dr and lymphoid-associated antigens cd19 and cd7. | |||||||
| 27544027 | HLA-DR (HLA-DR) | acute promyelocytic leukemia | NA | NA | NA | unclassified | |
| hla-dr antigen-positive acute promyelocytic leukemia. | |||||||
| 30315692 | HLA-DR (HLA-DR) | acute promyelocytic leukemia | NA | NA | NA | unclassified | |
| the cd9+ cd11b- hla-dr- immunophenotype can be used to diagnose acute promyelocytic leukemia. | |||||||
| 33598252 | HLA-DR (HLA-DR) | acute promyelocytic leukemia | NA | NA | NA | unclassified | |
| the triad of weak/absent cd34, negative hla-dr expression, and positivity to cd117 is pathognomonic for the diagnosis of acute promyelocytic leukemia. | |||||||
| 34459465 | HLA-DR (HLA-DR) | cytarabine | NA | arsenic | NA | only_studied | |
| NA | |||||||
Copyright 2024